β-HB inhibits the apoptosis of high glucose-treated astrocytes via activation of CREB/BDNF axis

OBJECTIVE: Nerve damage can cause severe limb dysfunction and even leave a lifelong disability. The apoptosis of astrocytes may contribute to the nerve damage. In this research, we sought to investigate the effect of β-HB on nerve damage in vitro.

DESIGN: Astrocytes were treated with high glucose (HG) to mimic in vitro model of nerve damage. RT-qPCR and western blot were used to detect expressions of CREB, BDNF, Ki-67, PCNA, Bax, Bcl-2 and cleaved caspase 3 in astrocytes, respectively. MTT was used to measure the cell viability. In addition, flow cytometry was used to detect the cell apoptosis.

RESULTS: β-HB significantly promoted the proliferation and inhibited apoptosis in HG-treated astrocytes. Results showed that of PCNA and Bcl-2 were upregulated, and Bax and cleaved caspase 3 were downregulated after β-HB stimulated in HG-treated astrocytes. In addition, HG-induced inhibition on BDNF expression in astrocytes was notably reversed by β-HB. Furthermore, β-HB promoted the growth and inhibited apoptosis of high glucose-treated astrocytes via activation of CREB/BDNF axis.

CONCLUSION: β-HB promotes the growth and inhibits the apoptosis of high glucose-treated astrocytes via activation of CREB/BDNF axis, which may serve as a new target for treatment of nerve damage.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:35

Enthalten in:

Brain injury - 35(2021), 10 vom: 24. Aug., Seite 1201-1209

Sprache:

Englisch

Beteiligte Personen:

Zhang, Lei [VerfasserIn]
Dong, Da-Long [VerfasserIn]
Gao, Jun-Hong [VerfasserIn]
Wang, An-Kui [VerfasserIn]
Shao, Yong-Ping [VerfasserIn]

Links:

Volltext

Themen:

β-HB
Astrocytes
Brain-Derived Neurotrophic Factor
CREB/BDNF axis
Glucose
IY9XDZ35W2
Journal Article
Nerve damage
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 11.10.2021

Date Revised 11.10.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/02699052.2021.1959061

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM329274686